ALCON -----Original Message----

From:
To:
Subject:
Date:
Attachments:
Importance:
Roche, Baruch CIV USARMY USAR MEDCOM (US)
Clark, Sheila D CIV USARMY MEDCOM (US); Graham, Kamelia S SSG USARMY USAR MEDCOM (US); Reese,
Tinamarie E MSG USARMY USAR MEDCOM (US); Finley, William B MAJ USARMY USAR MEDCOM (US); Grant,
Suzette M CPT USARMY USAR MEDCOM (US); Nikakis, Sean P MSG USARMY USAR MEDCOM (US); Rasheid,
Mohammad H 1LT USARMY USAR MEDCOM (US); Snyder, David J CIV USARMY USAR MEDCOM (US); Berg,
William C CIV USARMY USAR MEDCOM (US); Booth, James L LTC USARMY USAR MEDCOM (US);
[email protected]; Curtis, Dennis A MAJ USARMY USAR MEDCOM (US); Diorio, Ronald M MAJ
USARMY MEDCOM EAMC (US); Hartford, Ericka P 1LT USARMY (US); Maddox, Jonah M SSG USARMY 88 RSC
(US); Nguyen, Phong T 1LT USARMY (US); Price, Catherine L MAJ USARMY (US); Rivas, Stacee L CPT USARMY
MEDCOM (US); Sanders, Joan B MAJ USARMY MEDCOM MAMC (US); Wald, Timothy J CPT USARMY (US);
Baures, Chad M SFC USARMY USAR MEDCOM (US); Burkholder, Richard E 1SG USARMY USAR MEDCOM (US);
Heston, Robert R MSG USARMY USAR MEDCOM (US); Knight, Rodney D SFC USARMY (US); Mansaw, Brandon C
MSG USARMY USAR MEDCOM (US); Mitchell, Deborah Marie MSG USARMY MEDCOM AMEDDCS (US); Mitchenor,
Tamela L MAJ USARMY USAR MEDCOM (US); Paez, Christopher Ignac SFC USARMY USAR MEDCOM (US); Price,
Letroye S MSG USARMY USAR MEDCOM (US); Sendi, Paul SFC USARMY USAR MEDCOM (US); Brillhart, Jon C
MAJ USARMY (US); Calliste, Marcus P 1LT USARMY USAR MEDCOM (US); Davis, Candace L CIV USARMY USAR
MEDCOM (US); Fernandes, Antonio T CIV USARMY USAR MEDCOM (US); Kasipathy, Madhusudhan R MAJ
USARMY (US); Kuduk, Steven M CIV USARMY USAR MEDCOM (US); Lawson, Adria M CIV USARMY USAR
MEDCOM (US); Lilly, Brian W CPT USARMY (US); Osorio, Rodriguez J CPT USARMY MEDCOM (US); Patierno,
Rena L MAJ USARMY USAR MEDCOM (US); Scanlon, Andre E CPT USARMY (US); Shah, Shukan V CPT USARMY
(US); Travis, Nanci L CPT USARMY (US); Wheeler, Bruce W MAJ USARMY USAR MEDCOM (US); Alexander,
Denetra K CIV USARMY (US); Baisley, Christina L MAJ USARMY USAR MEDCOM (US); Boudreaux, Rondine D
MAJ USARMY 377 TSC (US); Brown, Lajuanda Y MAJ USARMY (US); Carroll, Charles W MAJ USARMY USAR
MEDCOM (US); Charleston, Arthur C MSG USARMY USARC HQ (US); Dulaney, Candice J CPT USARMY USAR
MEDCOM (US); Fields, Pamela L MSG USARMY USAR MEDCOM (US); Glass, Tiffany A CPT USARMY USAR
MEDCOM (US); Green, Adam W CPT USARMY (US); Hanna, Anthony G MAJ USARMY MEDCOM EAMC (US);
Hollomandawsey, Traci N MSG USARMY 81 RSC (US); King, Wilma A MAJ USARMY USAR MEDCOM (US);
Matthews, Taimania S (Tai) 1LT USARMY USAR MEDCOM (US); McGhee, June B LTC USARMY MEDCOM (US);
Nettles, Christopher B CPT USARMY MEDCOM EACH (US); White, Kevin M MSG USARMY 84 TNG CMD (US);
Wilson, George E Jr CPT USARMY (US); Wilson, Zanne L 1LT USARMY (US); Woodruff, Mildred Sue (Sue) CPT
USARMY (US); Clark, Gregory D (gregory.d.clark) SFC USARMY USAR MEDCOM (US); Levendoski, David D MAJ
USARMY USAR MEDCOM (US); Lyton, George E CPT USARMY USAR MEDCOM (US); Maak, Eugene C LTC
USARMY USAR MEDCOM (US); Manda, Kelly M CPT USARMY MEDCOM EAMC (US); Park, Young I 1LT USARMY
(US); Smith, Zakia W CPT USARMY USAR MEDCOM (US); Yuen, Kiu T CPT USARMY (US)
T1/T2S/T2RS Guidance
Tuesday, March 29, 2016 5:38:06 AM
Army FIS Implementation_01122016.pdf
Guidance for Civilian SHARP Program Positions_27 SEP 13.pdf
High
ALCON
-----Original Message----From: USARMY APG INSCOM Mailbox PSIP Requesters
Subject: T1/T2S/T2RS Guidance
Importance: High
ALCON,
1. Effective 1 April 2016, the Office of Personnel Management (OPM) will discontinue the National Agency Check
and Inquiries (NACI) and Moderate Risk Background Investigation (MBI) investigation types.
2. The Tier 1 (T1) investigation, currently the NACI investigation, is the initial investigation conducted in support of
low risk positions, non-sensitive positions, or for physical/logical access. Per Memorandum dated 12 January 2016,
'Army Federal Investigative Standards (FIS) Implementation', no reinvestigations are authorized for a T1/NACI
investigation (see attached).
3. The Tier 2S (T2S) investigation, currently the MBI, is the initial investigation conducted in support of moderate
risk public trust positions. The Memorandum dated 27 September 2013, 'Guidance for Civilian Sexual
Harassment/Assault Response and Prevention (SHARP) Program Positions", provides guidance for Civilian
employees performing duties as part of the SHARP program. This memorandum establishes the T2S/MBI as the
minimum investigation required for Sexual Assault Response Coordinator (SARC) and SHARP Victim Advocate
positions (see attached). 4. The Tier 2RS (T2RS) investigation is the reinvestigation conducted for a T2S/MBI investigation. Per Enclosure 1
of the Army FIS Implementation Memorandum (12 January 2016), the T2RS is required every (3) years for SARC
and SHARP positions. NOTE: Per Enclosure 1 of the Army FIS Implementation Memorandum (12 January 2016), all other T2RS
reinvestigations will be implemented under separate guidance.
5. Thank you for your patience and cooperation during the T1/T2 transition period. Please send any questions to the
PSIP Requester's mailbox at [email protected].
Thank You,
V/R
Brian Howard
Security Assistant / Plan & Initiatives (P&I)
Personnel Security Investigation Center of Excellence (PSI-CoE)
PSI - CoE Customer Support Center: 410-278-4194 / DSN 312-298-4194
Phone: (410)-306-1278 / DSN: 312- 458-1278
The PSI-CoE is committed to providing "world-class customer service" and appreciates your input. Please submit all
comments to ICE at:
https://ice.disa.mil/index.cfm?fa=card&sp=130685&s=161&dep=*DoD&sc=33